Shareholders Equity: The sum of preferred and common equity items.
Nanobiotix S.A. - Sponsored ADR (NBTX) had Shareholders Equity of $-38.81M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$143.57M |
|
$5.13M |
|
$5.64M |
|
$149.21M |
|
$99.91M |
|
-- |
|
$88.11M |
|
$188.02M |
|
$-38.81M |
|
$-38.82M |
|
|
Shareholders Equity |
$-38.81M |
50.83M |
|
| Cash Flow Statement Financials | |
$-21.13M |
|
$-0.67M |
|
$88.94M |
|
$61.33M |
|
$128.93M |
|
$67.60M |
|
$3.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|